// company-profile

Mineralys Therapeutics, Inc.

MLYS
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings128Insiders19
// api This Mineralys Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).

// 90-day insight

Over the last 90 days, Mineralys Therapeutics, Inc. insiders filed 50 Form 4 transactions, none of which were open-market purchases or sales.

  • Most active insider: Rodman David Malcom with 42 transactions totaling $2.3M.
  • Largest single sale: $494K by Congleton Jon on Mar 31, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Mineralys Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$2.56B
QoQ change
-21.4%
Reporting period
2026-03-31
#1
Catalys Pacific, LLC
CIK 2011385
$214.1M
7.9M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$208.4M
7.7M shares
#3
SAMSARA BIOCAPITAL, LLC
CIK 1744967
$159.0M
5.9M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Rodman David MalcomMLYS
Sale10b5
4,584$25.00$115K
Jun 17, 2026Rodman David MalcomMLYS
Option Exercise10b5
4,167$14.25$59K
Jun 17, 2026Rodman David MalcomMLYS
Option Exercise10b5
417$0.00$0K
Jun 17, 2026Karydas DaphneMLYS
Option Exercise10b5
3,000$0.00$0K
Jun 17, 2026Rodman David MalcomMLYS
Option Exercise10b5
4,167$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.